| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
NCT00546520: Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125) |
|
|
| Completed | 3 | 21 | Europe | Ciclesonide | AstraZeneca | Asthma | 06/02 | 06/02 | | |
NCT00163410: Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205) |
|
|
| Completed | 3 | 500 | RoW | Ciclesonide | AstraZeneca | Asthma | 12/04 | 12/04 | | |
NCT00659048: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) |
|
|
| Completed | 3 | 106 | US | Ciclesonide, Placebo | AstraZeneca | Rhinitis, Allergic, Perennial | 04/05 | 12/05 | | |
NCT00163488: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) |
|
|
| Completed | 3 | 106 | US | Ciclesonide | AstraZeneca | Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever | 08/05 | 08/05 | | |
NCT00174733: Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid |
|
|
| Completed | 3 | 456 | US | Ciclesonide (XRP1526) | Sanofi | Asthma | 02/06 | 02/06 | | |
| Completed | 3 | 1080 | Europe, RoW | Ciclesonide, Placebo, Salbutamol | AstraZeneca, Nycomed GmbH | Asthma | 08/07 | 08/08 | | |
NCT00163332: Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129) |
|
|
| Completed | 3 | 30 | Europe | Ciclesonide | AstraZeneca | Asthma | | | | |
